Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Tulip Brasília Alvorada Hotel

Sep 25, 2024 8:00 AM - Sep 26, 2024 4:00 PM

Shtn - Trechno 01, Conj 1Bb - Bloco C, 40800-200 Brasília, Brazil

Latin America Annual Meeting

Take advantage of opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America.

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

Overview

Forum: September 25-26

DIA is thrilled to announce our 2024 Latin America Annual Meeting that will include opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America and the Caribbean. This meeting expands in scope from our previous meetings discussing topics relating to the Latin America region, and presents the following three tracks: Regulatory/Clinical, Safety and Pharmacovigilance, and Medical Affairs and Scientific Communications (MASC). Cross-track sessions provide the opportunity to discuss key connection points across major components of regulatory, clinical, safety, pharmacovigilance, and medical affairs and scientific communications initiatives, efforts and collaboration within these functional areas in an organization or company. Join us to discuss multi-regional cooperation, global harmonization, lessons learned, and best practices to stimulate discussion and foster collaboration amongst stakeholders in Latin America and the Caribbean.

*The primary language is English, however simultaneous interpretation in Spanish and Portuguese will be available during this meeting.

While we develop our 2024 agenda, please take a moment to review the 2023 final agenda

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.

Participant Testimonials

The agenda was prepared including topics of great importance and current affairs. The exchange between the participants is very enriching and gives the possibility of listening first-hand to the experience of prestigious speakers. - Lisette Pérez Ojeda - CECMED, Colombia

It is an important event to share information/experiences, to access the current status and opportunities, to develop ourselves and to implement new strategies/skills/information into the work. – Patricia Dias - LEO Pharma, Brazil

Featured

Want to learn more about Latin America Annual Meeting? You've come to the right site!

Exhibits

Highlights & Features

Who should attend?

  • Professionals interested in:

    • Academia
    • Benefit-Risk Assessment and Communication
    • Clinical Research and Development
    • Clinical Operations
    • CROs/Vendors
    • Document Management/eSubmissions
    • Drug Regulation
    • Drug Safety/Pharmacovigilance
    • Field Medical
    • Global Submission/Project Management
    • Government Affairs
    • Manufacturing
    • Medical and Scientific Affairs
    • Medical Call Center Environment
    • Medical Communications
    • Medical Information
    • Medical Product Safety Assessment
    • Medical Science Liaisons
    • Medical Writing
    • Pharmacoepidemiology
    • Policy and Intelligence
    • Post-Market Studies
    • Quality Assurance and Compliance
    • Real-World Evidence
    • Regulatory Agencies
    • Regulatory Affairs, Operations, and Strategy
    • Research and Development
    • Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
    • Strategic Sourcing/Planning

Program Committee

  • Marta  Avellar
    Marta Avellar Medical Information Head, Latin America and North America Medical Information
    Takeda, Brazil
  • Josue  Bautista, PharmD
    Josue Bautista, PharmD GCP/PV Auditor
    Novartis, Mexico
  • Daniela  Bravo
    Daniela Bravo Regulatory Policy and Intelligence Manager
    AbbVie, Brazil
  • Arthur  Bueno, PharmD, MBA
    Arthur Bueno, PharmD, MBA Country Safety Head Back-Up
    Sanofi Brazil, Brazil
  • Raphael Elmadjian Pareschi, PharmD, MBA
    Raphael Elmadjian Pareschi, PharmD, MBA Patient Safety Lead/ Head of Pharmacovigilance Brazil
    Roche, Brazil
  • Flavia  Firmino Ribeiro, PharmD
    Flavia Firmino Ribeiro, PharmD Director Reg Global CMC
    Pfizer, Brazil
  • Carolina  Garcia, PharmD
    Carolina Garcia, PharmD Founder
    PGA Farma, Brazil
  • Cammilla  Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm LATAM Regulatory Policy Lead
    Roche, Brazil
  • Susan  Koepke, MBA
    Susan Koepke, MBA Head of Regulatory Affairs LATAM
    EMD Serono, Inc., United States
  • Lawrence  Liberti, PhD, RAC
    Lawrence Liberti, PhD, RAC Director, D.K. Kim International Center for Regulatory Science
    The Kim Center/ USC DRQS, United States
  • Mercedes  Lopez, MA
    Mercedes Lopez, MA Regional Operations Manager, Latin America
    WCG Clinical, United States
  • Elkiane Macedo Rama
    Elkiane Macedo Rama Advisor to the International Affairs Office
    Brazilian Health Regulatory Agency (ANVISA), Brazil
  • Viktoria  Magyar, LLM, MSc
    Viktoria Magyar, LLM, MSc Doctoral Student, Department of Regulatory and Quality Sciences
    USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
  • Rosana M. Mastellaro, PharmD, RPh
    Rosana M. Mastellaro, PharmD, RPh Director, Technical Regulatory Affairs and Innovation
    Sindusfarma, Brazil
  • Barbara  Nardi, PharmD
    Barbara Nardi, PharmD Global Director - Medical Communications
    Thermo Fisher Scientific, Brazil
  • Patricia  Oliveira Pereira Tagliari, LLM, MPH
    Patricia Oliveira Pereira Tagliari, LLM, MPH Associate Director
    ANVISA, Brazil
  • Lisette  Pérez Ojeda
    Lisette Pérez Ojeda Asesora de la Dirección
    CECMED, Colombia
  • Ana  Pineda Zavaleta, MSc
    Ana Pineda Zavaleta, MSc International Regulatory Analyst, LAO, OGPS, OPLIA, OC
    FDA, United States
  • Duglas  Rodriguez Calderon, MSc
    Duglas Rodriguez Calderon, MSc Head of LATAM Regulatory Policy, Global Regulatory Policy & Intelligence
    Roche, Panama
  • Maria Antonieta Tony Roman, MPharm
    Maria Antonieta Tony Roman, MPharm Head Regulatory Policy Emerging Markets LATAM
    Novartis, Mexico
  • Diego Alexander Salas, LLM
    Diego Alexander Salas, LLM Regulatory Affairs Director
    FEDERACION LATINOAMERICANA DE LA INDUSTRIA FARMACEUTICA, A.C., Mexico
  • Leonardo Semprun Semprun, PharmD
    Leonardo Semprun Semprun, PharmD Global Regulatory Policy Lead-LatAm
    MSD, Panama
  • Ricardo  Uribe, MBA
    Ricardo Uribe, MBA Head of Clinical FSPx Americas
    Fortrea Clinical Development Mexico, S. De R.L. de C.V., Mexico
  • Gislaine Villarta Capeleti Dib, PharmD
    Gislaine Villarta Capeleti Dib, PharmD Pharmacovigilance Manager
    PGA Farma, Brazil
  • Susan  Zavala Coloma, MS, RPh
    Susan Zavala Coloma, MS, RPh Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products
    DIGEMID, Peru
  • Representative Invited
    Representative Invited DIA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.